In an article titled “Bevacizumab plus fosbretabulin improves survival in ovarian cancer” (published November 10, 2014,) the headline did not clearly state that drug combination improves progression free survival. It does not improve overall survival.

Ads

You May Also Like

Acne gel works better in women

A gel combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% was significantly more ...